Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Current Opinion in Chemical Biology
|
July 27, 1999
Novel anticancer drug discovery
J K Buolamwini
Current Pharmaceutical Design
|
May 2, 2000
Cell cycle molecular targets in novel anticancer drug discovery
J K Buolamwini
Current Pharmaceutical Design
|
May 2, 2000
Molecular targets in cancer drug discovery: cell-based profiling
J N Weinstein, J K Buolamwini
Drug Design and Discovery
|
December 1, 1991
Synthesis and antinociceptive activity of 2- and 3-methyl derivatives of 4-(pyridyl) isosteres of meperidine
J K Buolamwini, E E Knaus
Drug Design and Discovery
|
July 1, 1992
Synthesis and antinociceptive activity of 1-[2-(pyridyl)ethyl] and 1-[2-(dihydropyridyl)ethyl] analogues of fentanyl
J K Buolamwini, E E Knaus
Drug Design and Delivery
|
July 1, 1988
Synthesis and antinociceptive activity of 7-aryloxysulfonyl piperidines
J K Buolamwini, E E Knaus
Drug Design and Delivery
|
December 1, 1990
Synthesis and antinociceptive activity of 4-pyridyl and -dihydropyridyl analogues of meperidine and ketobemidone
J K Buolamwini, E E Knaus
American Journal of Physiology. Heart and Circulatory Physiology
|
February 13, 2007
Cardioprotective effects of novel tetrahydroisoquinoline analogs of nitrobenzylmercaptopurine riboside in an isolated perfused rat heart model of acute myocardial infarction
Z Zhu, P A Hofmann, J K Buolamwini
Current Cancer Drug Targets
|
August 22, 2002
Antisense anticancer oligonucleotide therapeutics
H Wang, G Prasad, J K Buolamwini, et al.
Pharmaceutical Research
|
December 1, 1996
Application of the electrotopological state index to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitors
J K Buolamwini, K Raghavan, M R Fesen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Current Opinion in Chemical Biology
|
July 27, 1999
Novel anticancer drug discovery
J K Buolamwini
Current Pharmaceutical Design
|
May 2, 2000
Cell cycle molecular targets in novel anticancer drug discovery
J K Buolamwini
Current Pharmaceutical Design
|
May 2, 2000
Molecular targets in cancer drug discovery: cell-based profiling
J N Weinstein, J K Buolamwini
Drug Design and Discovery
|
December 1, 1991
Synthesis and antinociceptive activity of 2- and 3-methyl derivatives of 4-(pyridyl) isosteres of meperidine
J K Buolamwini, E E Knaus
Drug Design and Discovery
|
July 1, 1992
Synthesis and antinociceptive activity of 1-[2-(pyridyl)ethyl] and 1-[2-(dihydropyridyl)ethyl] analogues of fentanyl
J K Buolamwini, E E Knaus
Drug Design and Delivery
|
July 1, 1988
Synthesis and antinociceptive activity of 7-aryloxysulfonyl piperidines
J K Buolamwini, E E Knaus
Drug Design and Delivery
|
December 1, 1990
Synthesis and antinociceptive activity of 4-pyridyl and -dihydropyridyl analogues of meperidine and ketobemidone
J K Buolamwini, E E Knaus
American Journal of Physiology. Heart and Circulatory Physiology
|
February 13, 2007
Cardioprotective effects of novel tetrahydroisoquinoline analogs of nitrobenzylmercaptopurine riboside in an isolated perfused rat heart model of acute myocardial infarction
Z Zhu, P A Hofmann, J K Buolamwini
Current Cancer Drug Targets
|
August 22, 2002
Antisense anticancer oligonucleotide therapeutics
H Wang, G Prasad, J K Buolamwini, et al.
Pharmaceutical Research
|
December 1, 1996
Application of the electrotopological state index to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitors
J K Buolamwini, K Raghavan, M R Fesen, et al.
Page
of 2